Trends of Molecular Testing for Lung Cancer at the King Faisal Hospital, Kigali: Therapeutic and Survival Implications

Introduction: Lung cancer is the leading cause of cancer mortality worldwide, both in high and low resource settings. Knowledge has been generated elsewhere regarding molecular subtyping and subsequent targeted therapy development, contributing substantially to patient survival. Little is known on t...

Cijeli opis

Bibliografski detalji

Glavni autori:	Achille Van Christ Manirakiza, MD, Fidel Rubagumya, MD, Eulade Rugengamanzi, MD, Alphonsine Mukandekezi, MD, Jessica Beneyo, BMLS, Maurice Musoni, MD, Thierry Zawadi Muvunyi, MD
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2022-04-01
Serija:	JTO Clinical and Research Reports
Teme:	Lung cancer Molecular and biomarker testing Targeted therapy Rwanda LMICs
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2666364322000285
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!